A heteroallelic mutant mouse model: A new orthologue for human hyperphenylalaninemia

Molecular Genetics and Metabolism

Volumn 69, Issue 3, 2000, Pages 188-194

  Sarkissian, Christineh N ^a   Boulais, Danielle M ^a   McDonald, J David ^b   Scriver, Charles R ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b WICHITA STATE UNIVERSITY   (United States)

Author keywords

Heteroallelic; Hyperphenylalaninemia; New orthologous mouse model; Pah gene; Phenylketonuria

Indexed keywords

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CONTROLLED STUDY; CROSS BREEDING; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE LOCUS; HYPERPHENYLALANINEMIA; METABOLIC DISORDER; MOUSE; MUTAGENESIS; NONHUMAN; PATHOPHYSIOLOGY; PHENYLKETONURIA; PLASMA CLEARANCE; PRIORITY JOURNAL;

ANIMALIA; RODENTIA;

EID: 0034012174     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.2000.2974     Document Type: Article

References (26)

1. Scriver C R, Kaufman S, Eisensmith R C, Woo S LC. The hyperphenylalaninemias. Scriver C R, Beaudet A L, Sly W S, Valle D. The metabolic and molecular bases of inherited disease. 1995;1015-1075 McGraw-Hill, New York.
2. Scriver C R, Waters P J. Monogenic traits are not simple: Lessons from phenylketonuria. Trends Genet. 15:1999;267-272.
3. Shedlovsky A, McDonald J D, Symula D, Dove W. Mouse models of human phenylketonuria. Genetics. 134:1993;1205-1210.
4. McDonald J D. Using high-efficiency mouse germline mutagenesis to investigate complex biological phenomena: Genetic disease, behavior, and development. Proc Soc Exp Biol Med. 209:1995;303-308.
5. Scriver C R, Kaufman S, Woo S LC. The hyperphenylalaninemias. Scriver C R, Beaudet A L, Sly W S, Valle D. The metabolic basis of inherited disease. 1989;495-546 McGraw-Hill, New York.
6. Russell W L, Kelly E M, Hunsicker P R, Bangham J W, Maddux S C, Phipps E L. Specific locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc Natl Acad Sci USA. 76:1979;5818-5819.
7. hph-5: A mouse mutant deficient in phenylalanine hydroxylase. Proc Natl Acad Sci USA. 87:1990;1965-1967.
8. McDonald J D. The PKU mouse project: Its history, potential and implications. Acta Paediatr. 407:1994;122-123.
9. Bode V, McDonald J, Guenet J, Simon D. hph-1: A mouse mutant with hereditary hyperphenylalaninemia induced by ethylnitrosourea mutagenesis. Genetics. 118:1988;299-305.
10. Montanez C S, McDonald J D. Linkage analysis of the hph-1 mutation and the GTP-cyclohydrolase I structural gene. Mol Genet Metab. 68:1999;91-92.
11. McDonald J D, Charlton C K. Characterization of mutations at the mouse phenylalanine hydroxylase locus. Genomics. 39:1997;402-405.
12. Ledley F D, Grenett H E, Woo S L. Biochemical characterization of recombinant human phenylalanine hydroxylase produced in Escherichia coli. J Biol Chem. 262:1987;2228-2233.
13. Kaufman S. Phenylalanine 4-monooxygenase from rat liver. Methods Enzymol. 142:1987;3-17.
14. Ledley F D, Grenett H E, Dunbar B S, Woo S LC. Mouse phenylalanine hydroxylase, homology and divergence from human phenylalanine hydroxylase. Biochem J. 267:1990;399-406.
15. Cotton R GH, McAdam W, Jennings I, Morgan F J. A monoclonal antibody to aromatic amino acid hydroxylases. Biochem J. 255:1988;193-196.
16. Nasir J, Floresco S B, Ousky J R, Diewert V M, Richman J M, Zeisler J, Borowski A, Marth J D, Phillips A G, Hayden M R. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell. 81:1995;811-823.
17. Seamans J K, Phillips A G. Selective memory impairments produced by transient lidocaine-induced lesions of the nucleus accumbens in rats. Behav Neurosci. 108:1994;456-468.
18. Sarkissian C N, Shao Z, Blain F, Peevers R, Su H, Heft R, Chang T MS, Scriver C R. A different approach to treatment of phenylketonuria: Phenylalanine degradation with recombinant phenylalanine ammonia lyase. Proc Natl Acad Sci USA. 96:1999;2339-2344.
19. Diomede L, Romano G, Guiso G, Caccia S, Nava S, Salmona M. Interspecies and interstrain studies on the increased susceptibility to metrozol-induced convulsions in animals given aspartame. Food Chem Toxic. 29:1991;101-106.
20. Scriver, C, R, Kaufman, S. Hyperphenylalaninemia: Phenylalanine hydroxylase deficiency. In The metabolic and molecular bases of inherited disease, 8th ed. (Scriver, C, R, Beaudet, A, L, Sly, W, S, Valle, D, Eds.; Childs, B, Kinzler, K, W, Vogelstien, B, Assoc. Eds.). New York, McGraw-Hill, in press, 2000.
21. Nadeau J H. Maps of linkage and synteny homologies between mouse and man. Trends Genet. 5:1989;82-86.
22. Erlandsen H, Fusetti F, Martinez A, Hough E, Flatmark T, Stevens R C. Crystal structure of the catalytic domain of human phenylalanine hydroxylase reveals the structural basis for phenylketonuria. Nat Struct Biol. 4:1997;995-1000.
23. Fusetti F, Erlandsen H, Martinez A, Flatmark T, Stevens R C. Structure of tetrameric human phenylalanine hydroxylase and its implications for phenylketonuria. J Biol Chem. 273:1998;16962-16967.
24. Erlandsen H, Stevens R C. The structural basis of phenylketonuria. Mol Genet Metab. 68:1999;103-125.
25. Kacser H, Burns J A. The molecular basis of dominance. Genetics. 97:1981;639-666.
26. Zagreda L, Goodman J, Druin D P, McDonald D, Diamond A. Cognitive deficits in a genetic mouse model of the most common biochemical cause of human mental retardation. J Neurosci. 19:1999;6175-6182.